Occupational exposure to antineoplastic drugs in hospital environments: potential risk associated with contact with cyclophosphamide- and ifosfamide-contaminated surfaces.


Journal

Medycyna pracy
ISSN: 2353-1339
Titre abrégé: Med Pr
Pays: Poland
ID NLM: 0376642

Informations de publication

Date de publication:
24 Sep 2020
Historique:
pubmed: 16 7 2020
medline: 23 7 2021
entrez: 16 7 2020
Statut: ppublish

Résumé

Cyclophosphamide (CP) and ifosfamide (IP) contaminations have been detected in hospital environments. This study was conducted to determine if there was any contamination in the spaces (floors and door handles) between the hospital exit and the antineoplastic drugs (ADs) preparation and administration units. At the same time, the authors proposed a new automation of the analytical procedure to considerably decrease the time needed for sample preparation and analysis. To evaluate the ADs contamination of surfaces, 829 wipe tests were performed in a campaign involving 3 hospitals located in Italy. Sampling was performed using an innovative kit. The levels of ADs were measured in each wipe sample using liquid chromatography/triple quadrupole. On-line solid-phase extraction guarantees the construction of a robust and reproducible analytical method. The CP and IP recoveries from stainless steel, polycarbonate and polyvinyl chloride ranged >80%, and the wipe holders and the automation tested ensured desorption efficiencies close to 100% for both the ADs. Of the 552 wipes taken on the spaces between the hospital exit and the preparation, administration and pharmacy warehouse units, 22 were greater than or equal to the limit of quantification, all adjacent to the administration units. This study provides an insight into the exposure situation against ADs residues. In order to improve environmental monitoring programs, the authors propose to evaluate the ADs contamination also outside the preparation, administration and pharmacy warehouse units. Med Pr. 2020;71(5):519-29.

Sections du résumé

BACKGROUND BACKGROUND
Cyclophosphamide (CP) and ifosfamide (IP) contaminations have been detected in hospital environments. This study was conducted to determine if there was any contamination in the spaces (floors and door handles) between the hospital exit and the antineoplastic drugs (ADs) preparation and administration units. At the same time, the authors proposed a new automation of the analytical procedure to considerably decrease the time needed for sample preparation and analysis.
MATERIAL AND METHODS METHODS
To evaluate the ADs contamination of surfaces, 829 wipe tests were performed in a campaign involving 3 hospitals located in Italy. Sampling was performed using an innovative kit. The levels of ADs were measured in each wipe sample using liquid chromatography/triple quadrupole.
RESULTS RESULTS
On-line solid-phase extraction guarantees the construction of a robust and reproducible analytical method. The CP and IP recoveries from stainless steel, polycarbonate and polyvinyl chloride ranged >80%, and the wipe holders and the automation tested ensured desorption efficiencies close to 100% for both the ADs. Of the 552 wipes taken on the spaces between the hospital exit and the preparation, administration and pharmacy warehouse units, 22 were greater than or equal to the limit of quantification, all adjacent to the administration units.
CONCLUSIONS CONCLUSIONS
This study provides an insight into the exposure situation against ADs residues. In order to improve environmental monitoring programs, the authors propose to evaluate the ADs contamination also outside the preparation, administration and pharmacy warehouse units. Med Pr. 2020;71(5):519-29.

Identifiants

pubmed: 32667290
pii: 121069
doi: 10.13075/mp.5893.00931
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Cyclophosphamide 8N3DW7272P
Ifosfamide UM20QQM95Y

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

519-529

Informations de copyright

This work is available in Open Access model and licensed under a CC BY-NC 3.0 PL license.

Auteurs

Nicola Mucci (N)

University of Florence, Florence, Italy (Department of Experimental and Clinical Medicine).

Stefano Dugheri (S)

Careggi University Hospital, Florence, Italy (Industrial Hygiene and Toxicology Laboratory, Occupational Medicine Unit).

Andrea Farioli (A)

University of Bologna, Bologna, Italy (Department of Medical and Surgical Sciences).

Giacomo Garzaro (G)

University of Turin, Turin, Italy (Department of Public Health and Pediatric Sciences).

Venerando Rapisarda (V)

University of Catania, Catania, Italy (Department of Clinical and Experimental Medicine).

Marcello Campagna (M)

University of Cagliari, Cagliari, Italy (Department of Medical Sciences and Public Health).

Alessandro Bonari (A)

University of Florence, Florence, Italy (Department of Experimental and Clinical Medicine).

Giulio Arcangeli (G)

University of Florence, Florence, Italy (Department of Experimental and Clinical Medicine).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH